Proactive Investors - Run By Investors For Investors

Tilray posts higher revenues but widening losses after a busy quarter of acquisitions and expansions

The Nanaimo, BC-based company’s net loss increased to US$30.3 million, or $0.32 per share, compared to a loss of $5.2 million, or $0.07 per share, during the same period last year.
cannabis US dollars
Revenue for the quarter rose to US$23 million, compared to US$7.8 million during the year-ago period

Tilray Inc (NASDAQ:TLRY), the worldwide cannabis producer, posted higher revenues but widening losses thanks to its acquisitions and expansion plans in 1Q.

The Nanaimo, BC-based company’s net loss increased to US$30.3 million, or $0.32 per share, compared to a loss of $5.2 million, or $0.07 per share, during the same period last year.

Analysts were expecting a loss of around $0.23 for the quarter.

READ: Tilray unlikely to provide positive earnings until 2020, says Roth analyst

Revenue for the quarter rose to US$23 million (C$31 million), a 195% increase from US$7.8 million during the year-ago period.

“We are pleased with our first quarter results and the ongoing, substantial progress our team has made to position Tilray as a global leader in the cannabis industry,” said Brendan Kennedy, Tilray’s president and CEO.

Kennedy highlighted the progress that Tilray has made integrating its recent acquisitions of Manitoba Harvest and Natura Naturals, which accelerates the company’s entry into the United States hemp and CBD markets.

The company has also bulked up its presence in North America and Europe. “As we expand our operations around the world, we remain focused on making disciplined investments to maximize the multiple paths to value creation we are aggressively pursuing for our visionary investors,” Kennedy said.

Roth analyst weighs in

In an analyst note released Wednesday, Roth Capital Partners reiterated its Neutral rating but did not offer a price target, citing "unprecedented volatility."

Analyst Scott Fortune argued the company was "playing catch-up" in terms of acquiring long-term supply, but noted the high upside of CBD markets. 

Tilray is a global company focused on the research, cultivation, production and distribution of cannabis and cannabinoids in twelve countries and five continents.

Shares of Tilray dropped 4.8% to US$46.41 Wednesday morning.

—This story was updated to include a Roth analyst note—

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full TLRY profile View Profile

Tilray Inc Timeline

Related Articles

medicinal cannabis concept
January 30 2019
Zelda has released its December quarterly report confirming multiple trials are on track.
cannabis plant
June 17 2019
The company recently underwent a brand identity redesign and unveiled a new wknd! product line consisting of pre-rolls, vape pens and cannagars which it will launch in July in Washington State
cannabis extraction
April 09 2019
NextLeaf Solutions is developing intellectual property around converting the cannabis plant into infused products through a scalable, repeatable process
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use